SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024514
Filing Date
2020-05-12
Accepted
2020-05-12 10:58:38
Documents
64
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q phat-10q_20200331.htm 10-Q 1335994
2 EX-10.1 phat-ex101_133.htm EX-10.1 104238
3 EX-10.2 phat-ex102_134.htm EX-10.2 93257
4 EX-31.1 phat-ex311_6.htm EX-31.1 17841
5 EX-31.2 phat-ex312_7.htm EX-31.2 17968
6 EX-32.1 phat-ex321_9.htm EX-32.1 7435
7 EX-32.2 phat-ex322_8.htm EX-32.2 7429
  Complete submission text file 0001564590-20-024514.txt   6065141

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT phat-20200331.xml EX-101.INS 1179463
9 XBRL TAXONOMY EXTENSION SCHEMA phat-20200331.xsd EX-101.SCH 56411
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE phat-20200331_cal.xml EX-101.CAL 42036
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE phat-20200331_def.xml EX-101.DEF 194200
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE phat-20200331_lab.xml EX-101.LAB 437199
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE phat-20200331_pre.xml EX-101.PRE 339235
Mailing Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, SUITE 102 FLORHAM PARK NJ 07932 (877) 742-8466
Phathom Pharmaceuticals, Inc. (Filer) CIK: 0001783183 (see all company filings)

IRS No.: 824151574 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39094 | Film No.: 20867457
SIC: 2834 Pharmaceutical Preparations